| Olea europaea leaf extract alters microRNA expression in human glioblastoma cells B Tunca, G Tezcan, G Cecener, U Egeli, S Ak, H Malyer, G Tumen, A Bilir Journal of cancer research and clinical oncology 138, 1831-1844, 2012 | 79 | 2012 |
| Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients B Tunca, G Tezcan, G Cecener, U Egeli, A Zorluoglu, T Yilmazlar, S Ak, ... Journal of cancer research and clinical oncology 139, 691-702, 2013 | 76 | 2013 |
| Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer GG Eskiler, G Cecener, G Dikmen, U Egeli, B Tunca European journal of pharmaceutical sciences 120, 73-88, 2018 | 64 | 2018 |
| Triple negative breast cancer: new therapeutic approaches and BRCA status G Guney Eskiler, G Cecener, U Egeli, B Tunca Apmis 126 (5), 371-379, 2018 | 54 | 2018 |
| Ficus carica Latex Prevents Invasion Through Induction of Let-7d Expression in GBM Cell Lines G Tezcan, B Tunca, A Bekar, M Yalcin, S Sahin, F Budak, G Cecener, ... Cellular and molecular neurobiology 35, 175-187, 2015 | 51 | 2015 |
| microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells G Tezcan, B Tunca, A Bekar, M Preusser, AS Berghoff, U Egeli, ... Cellular and molecular neurobiology 34, 679-692, 2014 | 51 | 2014 |
| Cytogenetic findings on shoe workers exposed long-term to benzene. BT Tunca, U Egeli Environmental Health Perspectives 104 (suppl 6), 1313-1317, 1996 | 48 | 1996 |
| Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression G Tezcan, B Tunca, A Bekar, F Budak, S Sahin, G Cecener, U Egeli, ... American journal of cancer research 4 (5), 572, 2014 | 47 | 2014 |
| Assessment of molecular events in squamous and non-squamous cell lung carcinoma T Yakut, HJ Schulten, A Demir, D Frank, B Danner, Ü Egeli, C Gebitekin, ... Lung Cancer 54 (3), 293-301, 2006 | 47 | 2006 |
| Epigenetic approach to early-onset Parkinson’s disease: low methylation status of SNCA and PARK2 promoter regions IE Eryilmaz, G Cecener, S Erer, U Egeli, B Tunca, M Zarifoglu, B Elibol, ... Neurological research 39 (11), 965-972, 2017 | 41 | 2017 |
| Expressed gene fusions as frequent drivers of poor outcomes in hormone receptor–positive breast cancer KJ Matissek, ML Onozato, S Sun, Z Zheng, A Schultz, J Lee, K Patel, ... Cancer discovery 8 (3), 336-353, 2018 | 39 | 2018 |
| Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer G Guney Eskiler, G Cecener, U Egeli, B Tunca Pharmaceutical research 35, 1-20, 2018 | 36 | 2018 |
| Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer G Tezcan, B Tunca, S Ak, G Cecener, U Egeli World Journal of Gastrointestinal Oncology 8 (1), 83, 2016 | 36 | 2016 |
| MicroRNA expression patterns of tumors in early-onset colorectal cancer patients S Ak, B Tunca, G Tezcan, G Cecener, U Egeli, T Yilmazlar, E Ozturk, ... journal of surgical research 191 (1), 113-122, 2014 | 36 | 2014 |
| The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites Ü Egeli, L Özkan, B Tunca, S Kahraman, G Çeçener, E Ergül, K Engin Head & neck 22 (6), 591-598, 2000 | 36 | 2000 |
| BRCA1/2 Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients G Cecener, U Egeli, B Tunca, E Erturk, S Ak, S Gokgoz, I Tasdelen, ... Cancer investigation 32 (8), 375-387, 2014 | 34 | 2014 |
| Novel Germline BRCA1 and BRCA2 Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives U Egeli, G Cecener, B Tunca, I Tasdelen Cancer investigation 24 (5), 484-491, 2006 | 32 | 2006 |
| Esophageal atresia and tracheo-esophageal fistula in a patient with Digeorge syndrome SS Kilic, A Gurpinar, T Yakut, U Egeli, H Dogruyol Journal of pediatric surgery 38 (8), E21-E23, 2003 | 32 | 2003 |
| Analysis of chromosomal aberrations in shoe workers exposed long term to benzene. B Türkel, U Egeli Occupational and environmental medicine 51 (1), 50-53, 1994 | 32 | 1994 |
| The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma G Cecener, B Tunca, U Egeli, A Bekar, G Tezcan, E Erturk, N Bayram, ... Cellular and molecular neurobiology 32, 237-244, 2012 | 31 | 2012 |
